Wet AMD 2 Symposium

Related

• 

  Vision Threatening Complications in Patients With Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials

  Diana V Do, MD, FASRS

  Updates from the Field

  2019

• 

  First Time Results of VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy

  Omer Trivizki, MD, MBA

  Updates from the Field

  2025

• 

  AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: 6-month Results From a Phase 1/2 Clinical Trial

  Michel Michaelides, BSc, MB BS, MD(Res), FRCOphth, FACS

  Updates from the Field

  2020